Liang, Pan <br/><br/>
Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.  [electronic resource] 

 -  International journal of pharmaceutics  Jun 2020 
 - 119375 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2020.119375  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--chemistry<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Delayed-Action Preparations<br/>Dose-Response Relationship, Drug<br/>Drug Compounding<br/>Drug Liberation<br/>Drug Stability<br/>Drug Synergism<br/>Female<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Nanoparticles<br/>Sesquiterpenes--chemistry<br/>Solubility<br/>Sorafenib--chemistry<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays